Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 20 to 75~* Performance status 0 , 1, or 2 (ECOG)~* Hematopoietic WBC ≥ 4,000/mm\^3 Platelet ≥ 100,000/mm\^3~* Hepatic AST and ALT ≤ 2 times upper limit of normal(ULN) Total bilirubin ≤ 1.2mg/dL~* Renal BUN ≤ 25mg/dL Creatinine ≤ 1.5mg/dL~Exclusion Criteria:~* Prior anticancer treatment

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): UFT (uracil, tegafur)
- 2 (Type: OTHER): Surgery alone

Based on this trial design, predict the completion outcome and termination type (if applicable).